CLINICAL_TRIALS
research
· 2024-10-15
Clinical Trial Update: Evaluation of ProLife 10 FORTE on Gut Microbiota Composition in UC Patients [NA]
Summary
A recruiting study evaluating the effects of ProLife 10 FORTE on gut microbiota composition in patients with Ulcerative Colitis in remission.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Padova | Conditions: Ulcerative Colitis in Remission | NA | Status: RECRUITING